Litigation Details for Turlock Irrigation District v. Novartis Pharmaceuticals Corporation (S.D.N.Y. 2018)
✉ Email this page to a colleague
Turlock Irrigation District v. Novartis Pharmaceuticals Corporation (S.D.N.Y. 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-07-27 |
| Court | District Court, S.D. New York | Date Terminated | 2019-05-01 |
| Cause | 15:1 Antitrust Litigation (Monopolizing Trade) | Assigned To | Alvin K. Hellerstein |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 6,294,197; 6,395,728 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Turlock Irrigation District v. Novartis Pharmaceuticals Corporation
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Turlock Irrigation District v. Novartis Pharmaceuticals Corporation (S.D.N.Y. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-07-27 | 1 | Complaint | regard to U.S. Patent Nos. 6,294,197 (“the ‘197 Patent”) and 6,395,728 (the ‘728 Patent), both Par and…, Novartis filed a U.S. Patent Application for the ’197 Patent. In its patent application, Novartis described…Novartis patents covering Exforge. Both filed “Paragraph III” certifications against U.S. Patent No. 5,…manufacture generic Exforge before the ’197 Patent and ’728 Patent …expiration of the listed patent(s). A brand manufacturer has 30 days in which to list patents issued after approval | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
